
Ask a doctor about a prescription for CITICOLINE TEVA-RATIOPHARM 1000 mg ORAL SOLUTION
Prospectus: information for the patient
Citicolina Teva-ratiopharm 1000 mg oral solution EFG
Read the entire prospectus carefully before starting to take this medication,as it contains important information for you.
Contents of the prospectus
Citicolina Teva-ratiopharm belongs to a group of medications called psychostimulants and nootropics, which act by improving brain function.
Citicolina Teva-ratiopharm is used to treat memory and behavioral disorders due to:
Do not take CiticolinaTeva-ratiopharm
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take Citicolina Teva-ratiopharm
Children
Citicolina Teva-ratiopharm has not been adequately studied in children, so it should only be administered if your doctor considers it necessary.
TakingCiticolinaTeva-ratiopharmwith other medications
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Citicolina Teva-ratiopharm enhances the effects of L-Dopa, so it should not be administered at the same time as medications containing L-Dopa, without consulting your doctor. Medications containing L-Dopa are usually used to treat Parkinson's disease.
Citicolina Teva-ratiopharm should not be administered in conjunction with medications containing meclofenoxate, which is a brain stimulant medication.
Taking CiticolinaTeva-ratiopharmwith food and drinks
Citicolina Teva-ratiopharm can be taken with meals or outside of them.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Citicolina Teva-ratiopharm, like most medications, should not be administered if you are pregnant, think you may be, or are breastfeeding, unless your doctor considers it necessary.
Driving and using machines
No effects have been observed on the ability to drive and use machinery.
CiticolinaTeva-ratiopharmcontains sorbitol
Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to certain sugars, or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease in which the patient cannot break down fructose, consult your doctor before taking this medication.
Citicolina Teva-ratiopharm contains cochineal red
It may cause allergic reactions.
Citicolina Teva-ratiopharm contains parahydroxybenzoates
It may cause allergic reactions (possibly delayed).
Citicolina Teva-ratiopharm contains formaldehyde
It may cause stomach upset and diarrhea.
Citicolina Teva-ratiopharm contains sodium
This medication contains 83.83 mg of sodium (main component of table salt/cooking salt) per sachet. This is equivalent to 4.19% of the maximum daily sodium intake recommended for an adult.
Follow the administration instructions of this medication exactly as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The normal dose is 1 to 2 sachets per day, depending on the severity of your illness. It can be taken directly or dissolved in half a glass of water (120 ml) with meals or outside of them.

If you take more CiticolinaTeva-ratiopharmthan you should
Consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take CiticolinaTeva-ratiopharm
Take your dose as soon as you remember. Do not take a double dose to make up for forgotten doses.
If you interrupt treatment with CiticolinaTeva-ratiopharm
Your doctor will indicate the duration of your treatment with Citicolina Teva-ratiopharm. Do not suspend treatment before consulting your doctor.
If you have any other doubts about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medications, this medication can have adverse effects, although not all people experience them.
The adverse effects of this medication are very rare (may affect up to 1 in 10,000 patients). Headache, dizziness, nausea, occasional diarrhea, facial flushing, swelling of the limbs, and changes in blood pressure may occur. If you experience any of these or other symptoms, inform your doctor.
Reporting adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Medication Surveillance System for Human Use Website: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep out of sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after "CAD". The expiration date is the last day of the month indicated.
Store in the original packaging.
No special storage conditions are required.
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy. If you have any doubts, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of CiticolinaTeva-ratiopharm
Appearance of the product and package contents
Citicolina Teva-ratiopharm is a clear oral solution with a pink color, strawberry flavor, and odor, packaged in sachets.
It is presented in a package containing 10 sachets or 30 sachets in a multiple package (3 subunits of 10 sachets) with 10 ml of oral solution each.
Marketing authorization holder and manufacturer
Marketing authorization holder
Teva Pharma, S.L.U.
Anabel Segura 11, Edificio Albatros B, 1st floor.
28108 Alcobendas. Madrid. Spain
Manufacturer
STE PHARMA SYSTEMS, S.L.
Avda. Universitat Autònoma, 13
Parc Tecnològic del Vallès,
Cerdanyola del Vallès,
08290 Barcelona (Spain)
O
Galenicum Health, S.L.U.
Sant Gabriel, 50 Esplugues de Llobregat
08950 Barcelona (Spain)
O
SAG Manufacturing SLU
Crta N-I, Km 36
28750 San Agustin de Guadalix, Madrid (Spain)
O
INDUSTRIA QUIMICA Y FARMACEUTICA VIR, S.A.
C/Laguna 66-70. Polígono Industrial Urtinsa II.
Alcorcón
28923, Madrid (Spain)
Date of the last revision of this prospectus:February 2014
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)http://www.aemps.gob.es/
The average price of CITICOLINE TEVA-RATIOPHARM 1000 mg ORAL SOLUTION in November, 2025 is around 16.19 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for CITICOLINE TEVA-RATIOPHARM 1000 mg ORAL SOLUTION – subject to medical assessment and local rules.